Khalid Amin
Impact in
- Hematology top 2%
- Erythropoietin and Anemia Treatment
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Gastric Cancer Management and Outcomes 4
- Oncology 25
- Pancreatic and Hepatic Oncology Research 8
- Co-authors
- Zishan A. Haroon (16 shared papers)Murat O. Arcasoy (7 shared papers)Keith R. Laderoute (4 shared papers)Juan Orduña (2 shared papers)Merrill Knapp (1 shared paper)Joy M. Calaoagan (1 shared paper)Marc Foretz (1 shared paper)Benoı̂t Viollet (1 shared paper)
- Journals
- Diagnostic Cytopathology (11 papers)Cancer Research (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Cancer Biology & Therapy (3 papers)Blood (2 papers)
- Partner nations
- United StatesPakistanChina
In The Last Decade
Khalid Amin
106 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 142
- Hematology 496
- Cancer Research 320
- Oncology 339
- Molecular Biology 715
- Toxicology 34
Countries citing papers authored by Khalid Amin
This map shows the geographic impact of Khalid Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Amin more than expected).
Fields of papers citing papers by Khalid Amin
This network shows the impact of papers produced by Khalid Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Amin. The network helps show where Khalid Amin may publish in the future.
Co-authors
The 25 scholars most cited alongside Khalid Amin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 367 | |
| 2 | 2004 | 193 | |
| 3 | 2001 | 175 | |
| 4 | 2002 | 154 | |
| 5 | 2003 | 142 | |
| 6 | 2007 | 131 | |
| 7 | 2005 | 76 | |
| 8 | 2001 | 64 | |
| 9 | 2004 | 49 | |
| 10 | 2003 | 46 | |
| 11 | 2002 | 43 | |
| 12 | 2014 | 42 | |
| 13 | 2016 | 40 | |
| 14 | 2017 | 36 | |
| 15 | 2021 | 34 | |
| 16 | 2017 | 33 | |
| 17 | 2018 | 33 | |
| 18 | 2004 | 31 | |
| 19 | 2010 | 29 | |
| 20 | 2015 | 23 |
About Khalid Amin
Khalid Amin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Epidemiology, having authored 117 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Erythropoietin and Anemia Treatment (7 papers), Cancer, Hypoxia, and Metabolism (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Gastric Cancer Management and Outcomes (4 papers), Wound Healing and Treatments (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Gastrointestinal disorders and treatments (4 papers). The work is most often cited by research in Hematology (496 citations), Cancer Research (320 citations), Oncology (339 citations), Molecular Biology (715 citations) and Toxicology (34 citations). Khalid Amin has collaborated with scholars based in United States, Pakistan and China. Frequent co-authors include Zishan A. Haroon, Murat O. Arcasoy, Keith R. Laderoute, Juan Orduña, Merrill Knapp, Joy M. Calaoagan, Marc Foretz, Benoı̂t Viollet, Mark W. Dewhirst and Xiaohong Jiang. Their work appears in journals such as Diagnostic Cytopathology, Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Cancer Biology & Therapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.